Avobis Bio presents at the 2024 Cell and Gene Meeting on the Mesa

Sunset view of Phoenix for Meeting on the Mesa

Tiffany Brown, PhD, Chief Executive Officer, presented at the 2024 Cell and Gene Meeting on the Mesa in Phoenix, AZ on October 9, 2024.

Meeting on the Mesa is the sector’s foremost annual conference that serves as a crucial platform for industry leaders to discuss advancements, challenges, and future directions in cell and gene therapy, making it a significant event in the biotech calendar.  2024 brought together more than 2,000 attendees.

Tiffany J. Brown, PhD

Chief Executive Officer

Tiffany leads Avobis Bio as Chief Executive Officer, Chief Compliance Officer and Board Member. She has been passionate about regenerative medicine for 25 years and focused her career on ensuring patients have access to therapies to transform their lives. In her early career, Tiffany developed new products from clinical concept through technology development, global regulatory approvals and commercial sales. She went on to lead a multi-million dollar global portfolio of therapeutics for general surgical, bariatric and colorectal conditions with assets from pre-clinical stage to market leaders. Tiffany was instrumental in the formation of Avobis Bio, bringing together capabilities of Gore and Mayo Clinic, establishing the team and accelerating operational execution. She holds a PhD in Biomedical Engineering from Georgia Tech and Emory University. Tiffany enjoys immersion in global cultures, opportunities to travel and staying active with her husband and children.